Standard Bank Group Limited Form 8.5 (EPT/NON-RI) (8082A)
26 Mai 2023 - 10:29AM
UK Regulatory
TIDM68IG TIDMMDC
RNS Number : 8082A
Standard Bank Group Limited
26 May 2023
FORM 8.5 (EPT/NON-RI)
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN
EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI")
STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Name of exempt principal trader:
* Standard Bank of South Africa Limited
* SBG Securities (Pty) Ltd
(b) Name of offeror/offeree in relation to whose relevant securities Mediclinic International Plc
this form relates:
Use a separate form for each offeror/offeree
---------------------------------------------
(c) Name of the party to the offer with which exempt principal trader Mediclinic International Plc
is connected:
---------------------------------------------
(d) Date position held/dealing undertaken: 25 May 2023
For an opening position disclosure, state the latest practicable date
prior to the disclosure
---------------------------------------------
(e) In addition to the company in 1(b) above, is the exempt principal N/A
trader making disclosures
in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
---------------------------------------------
2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER
If there are positions or rights to subscribe to disclose in
more than one class of relevant securities of the offeror or
offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for
each additional class of relevant security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates following
the dealing (if any)
Class of relevant security: 10p ordinary
Interests Short positions
---------------- ------------------
Number % Number %
-------- ------ ---------- ------
(1) Relevant securities owned and/or controlled: 208 574 0.028
-------- ------ ---------- ------
(2) Cash-settled derivatives: 208 574 0.028
-------- ------ ---------- ------
(3) Stock-settled derivatives (including options) and agreements to
purchase/sell:
-------- ------ ---------- ------
TOTAL*: 208 574 0.028 208 574 0.028
-------- ------ ---------- ------
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions
(including traded options), or agreements to purchase or sell
relevant securities, should be given on a Supplemental Form 8 (Open
Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security in relation to which subscription right exists: None
Details, including nature of the rights concerned and relevant percentages: None
-----
3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of
relevant securities of the offeror or offeree named in 1(b), copy
table 3(a), (b), (c) or (d) (as appropriate) for each additional
class of relevant security dealt in.
The currency of all prices and other monetary amounts should be
stated.
(a) Purchases and sales
Class of relevant Purchases/ sales Total number of Highest price per Lowest price per unit
security securities unit paid/received paid/received
(ZAR) (ZAR)
10p ordinary MEI:SJ Purchase 36 639 118,46 117,96
------------------ ----------------------- ---------------------- -----------------------
10p ordinary MEI:SJ Sale -24 590 118,30 117,99
------------------ ----------------------- ---------------------- -----------------------
(b) Cash-settled derivative transactions
Class of relevant Product description Nature of dealing Number of reference Price per unit
security e.g. CFD e.g. opening/closing a securities (ZAR)
long/short position, (ZAR)
increasing/reducing a
long/short position
Short Position
10p ordinary MEI:SJ CFD Increasing -35 036 118,20
--------------------- ------------------------- ------------------------ ---------------
Short Position
10p ordinary MEI:SJ CFD Decreasing 22 987 118,25
--------------------- ------------------------- ------------------------ ---------------
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number of Exercise Type Expiry date Option money
relevant description purchasing, securities price per e.g. paid/
security e.g. call selling, to which unit American, received per
option varying etc. option European unit
relates etc.
(ii) Exercise
Class of relevant Product description Exercising/ exercised Number of securities Exercise price per
security e.g. call option against unit
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable)
e.g. subscription, conversion
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal
or informal, relating to relevant securities which may be an inducement to deal or refrain
from dealing entered into by the exempt principal trader making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such
agreements, arrangements or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the exempt
principal trader making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which
any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
None
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? No
Date of disclosure: 26 May 2023
Contact name: SBSA Global Markets Compliance
-------------------------------
Telephone number: +27 11 415 4465
-------------------------------
Public disclosures under Rule 8 of the Code must be made to a
Regulatory Information Service.
The Panel's Market Surveillance Unit is available for
consultation in relation to the Code's disclosure requirements on
+44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk .
, the news service of the London Stock Exchange. RNS is approved by
the Financial Conduct Authority to act as a Primary Information
Provider in the United Kingdom. Terms and conditions relating to
the use and distribution of this information may apply. For further
information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
FEOUNUWROVUVURR
(END) Dow Jones Newswires
May 26, 2023 04:29 ET (08:29 GMT)
Mediclinic (LSE:MDC)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Mediclinic (LSE:MDC)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
